HRT Financial’s Dianthus Therapeutics DNTH Stock Holding History

HRT Financial’s Portfolio DNTH Stock Details DNTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,997	Closed	-$199K	–	2816
2025 Q1	$199K	Buy	+10,997	New	+$242K	﹤0.01%	2033
2024 Q2	–	Sell	-34,174	Closed	-$1.02M	–	2409
2024 Q1	$1.02M	Buy	+34,174	New	+$743K	0.01%	875
2022 Q1	–	Sell	-3,068	Closed	-$217K	–	3261
2021 Q4	$217K	Buy	3,068 +1,844	+151%	+$185K	﹤0.01%	2483
2021 Q3	$142K	Buy	+1,224	New	+$143K	﹤0.01%	2797
2020 Q1	–	Sell	-773	Closed	-$187K	–	891
2019 Q4	$187K	Buy	+773	New	+$144K	0.01%	956

Other funds holding DNTH

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return